Novel transurethral resection technologies and training modalities in the management of nonmuscle invasive bladder cancer: a comprehensive review
Standard
Novel transurethral resection technologies and training modalities in the management of nonmuscle invasive bladder cancer: a comprehensive review. / Schuettfort, Victor M; Pradere, Benjamin; Compérat, Eva; Abufaraj, Mohammad; Shariat, Shahrokh F.
In: CURR OPIN UROL, Vol. 31, No. 4, 01.07.2021, p. 324-331.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Novel transurethral resection technologies and training modalities in the management of nonmuscle invasive bladder cancer: a comprehensive review
AU - Schuettfort, Victor M
AU - Pradere, Benjamin
AU - Compérat, Eva
AU - Abufaraj, Mohammad
AU - Shariat, Shahrokh F
N1 - Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2021/7/1
Y1 - 2021/7/1
N2 - PURPOSE OF REVIEW: Conventional transurethral resection (TURBT) with tumor fragmentation is the primary step in the surgical treatment of nonmuscle invasive bladder cancer. Recently, new surgical techniques and training modalities have emerged with the aim to overcome short-comings of TURBT and improve oncologic outcomes. In this review, we provide a comprehensive update of recent techniques/techniques that aim to improve upon conventional TURBT and beyond.RECENT FINDINGS: A systemic approach during conventional TURBT that features the use of a surgical checklist has been shown to improve recurrence-free survival. Several simulators have been developed and validated to provide additional training opportunities. However, transfer of improved simulator performance into real world surgery still requires validation. While there is no convincing data that demonstrate superior outcomes with bipolar TURBT, en-bloc resection already promises to offer lower rates of complications as well as potentially lower recurrence probabilities in select patients.SUMMARY: TURBT remains the quintessential procedure for the diagnosis and treatment of bladder cancer. Urologists need to be aware of the importance and challenges of this procedure. Aside of embracing new resection techniques and a conceptual-systematic approach, training opportunities should be expanded upon to improve patient outcomes.
AB - PURPOSE OF REVIEW: Conventional transurethral resection (TURBT) with tumor fragmentation is the primary step in the surgical treatment of nonmuscle invasive bladder cancer. Recently, new surgical techniques and training modalities have emerged with the aim to overcome short-comings of TURBT and improve oncologic outcomes. In this review, we provide a comprehensive update of recent techniques/techniques that aim to improve upon conventional TURBT and beyond.RECENT FINDINGS: A systemic approach during conventional TURBT that features the use of a surgical checklist has been shown to improve recurrence-free survival. Several simulators have been developed and validated to provide additional training opportunities. However, transfer of improved simulator performance into real world surgery still requires validation. While there is no convincing data that demonstrate superior outcomes with bipolar TURBT, en-bloc resection already promises to offer lower rates of complications as well as potentially lower recurrence probabilities in select patients.SUMMARY: TURBT remains the quintessential procedure for the diagnosis and treatment of bladder cancer. Urologists need to be aware of the importance and challenges of this procedure. Aside of embracing new resection techniques and a conceptual-systematic approach, training opportunities should be expanded upon to improve patient outcomes.
KW - Cystectomy/adverse effects
KW - Humans
KW - Neoplasm Recurrence, Local
KW - Urinary Bladder Neoplasms/surgery
KW - Urologic Surgical Procedures/adverse effects
KW - Urologists
U2 - 10.1097/MOU.0000000000000892
DO - 10.1097/MOU.0000000000000892
M3 - SCORING: Review article
C2 - 33973535
VL - 31
SP - 324
EP - 331
JO - CURR OPIN UROL
JF - CURR OPIN UROL
SN - 0963-0643
IS - 4
ER -